Total Payments
$679,937
2024 Payments
$176,082
Companies
18
Transactions
1,106
Medicare Patients
182
Medicare Billing
$23,664
Payment Breakdown by Category
Other$472,147 (69.4%)
Travel$134,199 (19.7%)
Consulting$56,636 (8.3%)
Food & Beverage$16,208 (2.4%)
Research$692.11 (0.1%)
Education$55.36 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $472,147 | 248 | 69.4% |
| Travel and Lodging | $134,199 | 320 | 19.7% |
| Consulting Fee | $56,636 | 29 | 8.3% |
| Food and Beverage | $16,208 | 505 | 2.4% |
| Unspecified | $692.11 | 2 | 0.1% |
| Education | $55.36 | 2 | 0.0% |
Payments by Type
General
$679,245
1,104 transactions
Research
$692.11
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $524,749 | 766 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $65,331 | 91 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $62,530 | 92 | $0 (2024) |
| Biogen, Inc. | $12,688 | 5 | $0 (2023) |
| Allergan, Inc. | $6,682 | 8 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $5,371 | 49 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,000 | 1 | $0 (2024) |
| Alkermes, Inc. | $385.14 | 12 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $304.29 | 23 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $248.16 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $176,082 | 228 | ABBVIE INC. ($130,060) |
| 2023 | $229,425 | 330 | ABBVIE INC. ($156,552) |
| 2022 | $173,739 | 322 | ABBVIE INC. ($149,765) |
| 2021 | $100,691 | 226 | AbbVie Inc. ($88,372) |
All Payment Transactions
1,106 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: Neurology | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.44 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Consulting Fee | Cash or cash equivalent | $2,760.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,220.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,220.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $31.54 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.07 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $632.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $434.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $403.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.44 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $1,323.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $406.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $65.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $406.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 78 | $12,280 | $4,566 |
| 2022 | 2 | 29 | 65 | $11,490 | $6,100 |
| 2021 | 2 | 86 | 239 | $47,440 | $10,543 |
| 2020 | 1 | 36 | 76 | $15,200 | $2,455 |
Total Patients
182
Total Services
458
Medicare Billing
$23,664
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 49 | $7,350 | $2,498 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 29 | $4,930 | $2,068 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 51 | $8,270 | $4,351 | 52.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 14 | 14 | $3,220 | $1,749 | 54.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 74 | 227 | $45,400 | $9,380 | 20.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2021 | 12 | 12 | $2,040 | $1,164 | 57.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 36 | 76 | $15,200 | $2,455 | 16.2% |
About Tina Matthews-Hayes, MSN, PMHNP-BC, FNP-C
Tina Matthews-Hayes, MSN, PMHNP-BC, FNP-C is a Registered Nurse healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/27/2010. The National Provider Identifier (NPI) number assigned to this provider is 1063726578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tina Matthews-Hayes, MSN, PMHNP-BC, FNP-C has received a total of $679,937 in payments from pharmaceutical and medical device companies, with $176,082 received in 2024. These payments were reported across 1,106 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($472,147).
As a Medicare-enrolled provider, Matthews-Hayes has provided services to 182 Medicare beneficiaries, totaling 458 services with total Medicare billing of $23,664. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Nurse Practitioner, Psychiatric/Mental Health
- Location Portland, OR
- Active Since 07/27/2010
- Last Updated 04/11/2024
- Taxonomy Code 163W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063726578
Products in Payments
- VRAYLAR (Drug) $524,942
- SPRAVATO (Drug) $65,273
- INGREZZA (Drug) $62,508
- UZEDY (Drug) $4,935
- ABILIFY ASIMTUFII (Drug) $1,036
- QULIPTA (Drug) $920.00
- QELBREE (Drug) $232.27
- CAPLYTA (Drug) $228.70
- LATUDA (Drug) $227.41
- LYBALVI (Drug) $213.12
- Austedo XR (Drug) $191.75
- ABILIFY MAINTENA (Drug) $181.80
- ARISTADA (Drug) $172.02
- REXULTI (Drug) $86.19
- Azstarys (Drug) $60.92
- INVEGA SUSTENNA (Drug) $58.70
- COBENFY (Drug) $48.94
- AZSTARYS (Drug) $41.44
- Qelbree (Drug) $15.89
- VYVANSE (Drug) $15.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Portland
Mrs. Leah Wessenberg, Fnp, FNP
Registered Nurse — Payments: $17,616
Registered Nurse $17,616
Kara Liechty, Cns-Pp, CNS-PP
Registered Nurse — Payments: $1,759
Registered Nurse $1,759
Rhezarie Mae Agtarap, Np-C, NP-C
Registered Nurse — Payments: $1,148
Registered Nurse $1,148
Sarah Storniolo, Nurse Practitioner, NURSE PRACTITIONER
Registered Nurse — Payments: $1,139
Registered Nurse $1,139
Mrs. Amy Ruhoff, R.n., M.s.n., Cns, R.N., M.S.N., CNS
Registered Nurse — Payments: $940.25
Registered Nurse $940.25
Ms. Nicole Ransbottom, Agacnp, AGACNP
Registered Nurse — Payments: $727.84
Registered Nurse $727.84